RECIST and iRECIST criteria for the evaluation of nivolumab plus ipilimumab combination in patients (pts) with microsatellite instability-high/mismatch repair-deficient (MSI/dMMR) metastatic colorectal cancer (mCRC): Results of the GERCOR NIPICOL phase II

Affiliation auteurs!!!! Error affiliation !!!!
TitreRECIST and iRECIST criteria for the evaluation of nivolumab plus ipilimumab combination in patients (pts) with microsatellite instability-high/mismatch repair-deficient (MSI/dMMR) metastatic colorectal cancer (mCRC): Results of the GERCOR NIPICOL phase II
Type de publicationJournal Article
Year of Publication2020
AuteursCohen R, Bennouna J, Henriques J, Tournigand C, de la Fouchardiere C, Tougeron D, Borg C, Mazard T, Chibaudel B, Garcia-Larnicol M-L, Svrcek M, Vernerey D, Menu Y, Andre T
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume38
Date PublishedFEB 1
Type of ArticleMeeting Abstract
ISSN0732-183X